Article | March 14, 2024

Nevada Filing Deadlines are Approaching: What Manufacturers Need to Know

Read More

Article | March 12, 2024

FDA Issues Numerous Warning Letters

Read More

Article | March 06, 2024

CCPA Regulations to Take Effect Immediately

Read More

Article | March 04, 2024

Highlights from OIG’s New Compliance Program Guidance

Read More

Article | February 29, 2024

New Jersey Passes Comprehensive Consumer Privacy Law

Read More

Article | February 21, 2024

FDA’s CDER Issues FY2023 Annual Report

Read More

Article | February 13, 2024

What does FDA think of AI?

Read More

Article | February 06, 2024

CMS Auditing Companies for Sunshine Compliance: Are You Ready?

Read More

Article | January 29, 2024

FDA Intensifies Efforts on LDT Regulation

Read More

Article | January 24, 2024

Court Affirms Criminal Convictions for Device Execs Under the FDCA

Read More

Article | January 22, 2024

FDA Issues Draft Guidance on Real-World Evidence Use

Read More

Article | January 10, 2024

US State Privacy Law Replay 2023

Read More

Article | December 12, 2023

Artificial Intelligence: Engaging FDA

Read More

Article | December 04, 2023

Med-Tech Meets High-Tech: Privacy, Cybersecurity and AI in Connected Devices

Read More

Article | November 28, 2023

Compliance Considerations in High-Tech Healthcare

Read More

Article | October 02, 2023

Gardner Law Attorneys Named 2023 Minnesota Rising Stars

Read More

Article | September 13, 2023

OPDP is Back Sending Untitled Letters after a Yearlong Hiatus

Read More

Article | August 22, 2023

Panel Session Recap: Navigating the M&A Waters of FDA-Regulated Companies

Read More

Article | August 07, 2023

FDA Regulatory, Compliance, and Privacy Due Diligence — Finding Your Goldilocks Zone

Read More

Article | August 07, 2023

Data Privacy Framework Across the Pond

Read More

Article | July 25, 2023

FDA's Proposed Compliance "Revamp": What Does It Mean for the Agency, Industry, and Consumers?

Read More

Article | July 20, 2023

State Registration Enforcement

Read More

Article | July 17, 2023

FDA Publishes First Draft Guidance for Clinical Trials with Psychedelic Drugs

Read More

Article | June 27, 2023

Getting What You Paid For: Acquisition Claims Considerations

Read More